Archbold Medical Center| Archives Magazine | Winter 2018

Nearly 80 percent of patients achieve 50 percent or greater pain relief in 24 months. ARCHBOLD.ORG • WINTER 2018 7 Dealing with chronic pain? Learn more about HF10™ and how the neurosurgeons at Archbold can help. Call 229.226.8880 or visit www.archbold.org/ neurosurgery . HF10™ safely delivers stimulation that doesn’t interfere with normal sensory perception, cognitive abilities or motor functions. It doesn’t interact with pain medications or require major surgery, and it is completely reversible. With HF10™ therapy, people with chronic pain have the freedom to move without tingling, prickling or buzzing and will not experience uncom- fortable stimulation or unexpected shocks. This therapy does not call for any restrictions on sleeping, and patients are able to drive while using it. Compared to other pain management options, HF10™ isn’t addictive, and it doesn’t cloud thoughts or cause drows- iness and constipation like some pain medications do. Effective results Controlled trials have shown that nearly 80 percent of patients achieve 50 per- cent or greater pain relief in 24 months and that the therapy is highly effective for both back and leg pain. The procedure to place HF10™ is also easier on both the physician and the patient. During the quick and minimally invasive procedure, a small device is implanted under the skin, just near the belt line or in the but- tocks area. It’s connected to thin, flexible wires that are placed near the spine. Implanting HF10™ is typically an out- patient procedure, which means patients can usually go home the same day. “After reviewing a year of results, I’ve found that my patients who have been using the HF10™ have reported great out- comes and relief from pain,” Dr. Kadis said. “It’s definitely an option that has proven effective for patients who are struggling with debilitating chronic pain.”

RkJQdWJsaXNoZXIy ODQ1MTY=